
Marsha M. Tsay
Examiner (ID: 332, Phone: (571)272-2938 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1124 |
| Issued Applications | 471 |
| Pending Applications | 130 |
| Abandoned Applications | 543 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8821538
[patent_doc_number] => 20130122583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'STERILIZATION PROCESS'
[patent_app_type] => utility
[patent_app_number] => 13/561787
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10325
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13561787
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/561787 | STERILIZATION PROCESS | Jul 29, 2012 | Abandoned |
Array
(
[id] => 9280379
[patent_doc_number] => 20140030347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'MASS PRODUCTION OF READY-TO-USE SUSPENSIONS OF FIBRINOGEN-COATED ALBUMIN SPHERES FOR THE TREATMENT OF THROMBOCYTOPENIC PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/560727
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11559
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560727
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/560727 | MASS PRODUCTION OF READY-TO-USE SUSPENSIONS OF FIBRINOGEN-COATED ALBUMIN SPHERES FOR THE TREATMENT OF THROMBOCYTOPENIC PATIENTS | Jul 26, 2012 | Abandoned |
Array
(
[id] => 8638350
[patent_doc_number] => 20130030153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'CROSSLINKED HUMAN OR ANIMAL TISSUE PRODUCTS AND THEIR METHODS OF MANUFACTURE AND USE'
[patent_app_type] => utility
[patent_app_number] => 13/560696
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13154
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560696
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/560696 | Crosslinked human or animal tissue products and their methods of manufacture and use | Jul 26, 2012 | Issued |
Array
(
[id] => 8721217
[patent_doc_number] => 20130072434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'INACTIVATION RESISTANT FACTOR VIII'
[patent_app_type] => utility
[patent_app_number] => 13/542010
[patent_app_country] => US
[patent_app_date] => 2012-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 17811
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13542010
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/542010 | INACTIVATION RESISTANT FACTOR VIII | Jul 4, 2012 | Abandoned |
Array
(
[id] => 12199893
[patent_doc_number] => 09902952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-27
[patent_title] => 'Euglobulin-based method for determining the biological activity of defibrotide'
[patent_app_type] => utility
[patent_app_number] => 14/408272
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5258
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408272
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/408272 | Euglobulin-based method for determining the biological activity of defibrotide | Jun 21, 2012 | Issued |
Array
(
[id] => 10226246
[patent_doc_number] => 20150111238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'METHOD FOR DETECTING DISEASE BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 14/123192
[patent_app_country] => US
[patent_app_date] => 2012-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10335
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123192
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/123192 | METHOD FOR DETECTING DISEASE BIOMARKERS | May 30, 2012 | Abandoned |
Array
(
[id] => 8381414
[patent_doc_number] => 20120225041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING TISSUE USING SILK PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/472328
[patent_app_country] => US
[patent_app_date] => 2012-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7893
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472328
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/472328 | Methods and compositions for treating tissue using silk proteins | May 14, 2012 | Issued |
Array
(
[id] => 8381413
[patent_doc_number] => 20120225040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING TISSUE USING SILK PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/472324
[patent_app_country] => US
[patent_app_date] => 2012-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7893
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472324
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/472324 | Methods and compositions for treating tissue using silk proteins | May 14, 2012 | Issued |
Array
(
[id] => 9455217
[patent_doc_number] => 08716225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'Kallikrein inhibitors and anti-thrombolytic agents and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/458086
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18607
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458086
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/458086 | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof | Apr 26, 2012 | Issued |
Array
(
[id] => 8476754
[patent_doc_number] => 20120276161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'BIORESORBABLE AND BIOCOMPATIBLE COMPOUNDS FOR SURGICAL USE'
[patent_app_type] => utility
[patent_app_number] => 13/458573
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7435
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458573
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/458573 | Bioresorbable and biocompatible compounds for surgical use | Apr 26, 2012 | Issued |
Array
(
[id] => 9306068
[patent_doc_number] => 20140044742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'METHOD FOR PREPARING A DEPLETED PLASMA MATERIAL CONSISTING OF ONE OR MORE THROMBOGENIC FACTORS'
[patent_app_type] => utility
[patent_app_number] => 14/112181
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5094
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112181
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112181 | METHOD FOR PREPARING A DEPLETED PLASMA MATERIAL CONSISTING OF ONE OR MORE THROMBOGENIC FACTORS | Apr 18, 2012 | Abandoned |
Array
(
[id] => 8323560
[patent_doc_number] => 20120195967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'SILK-BASED DRUG DELIVERY SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 13/443264
[patent_app_country] => US
[patent_app_date] => 2012-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7679
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13443264
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/443264 | Silk-based drug delivery system | Apr 9, 2012 | Issued |
Array
(
[id] => 8509233
[patent_doc_number] => 20120308641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'Compositions and Methods for Enhancing Coagulation Factor VIII Function'
[patent_app_type] => utility
[patent_app_number] => 13/437486
[patent_app_country] => US
[patent_app_date] => 2012-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11004
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13437486
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/437486 | Compositions and methods for enhancing coagulation Factor VIII function | Apr 1, 2012 | Issued |
Array
(
[id] => 9355309
[patent_doc_number] => 08673842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Polypeptoid pulmonary surfactants'
[patent_app_type] => utility
[patent_app_number] => 13/385310
[patent_app_country] => US
[patent_app_date] => 2012-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 11128
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13385310
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/385310 | Polypeptoid pulmonary surfactants | Feb 12, 2012 | Issued |
Array
(
[id] => 8483798
[patent_doc_number] => 20120283205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/368250
[patent_app_country] => US
[patent_app_date] => 2012-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19535
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13368250
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/368250 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | Feb 6, 2012 | Abandoned |
Array
(
[id] => 8982281
[patent_doc_number] => 08513396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Peptides and related molecules that modulate nerve growth factor activity'
[patent_app_type] => utility
[patent_app_number] => 13/364015
[patent_app_country] => US
[patent_app_date] => 2012-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 24527
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13364015
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/364015 | Peptides and related molecules that modulate nerve growth factor activity | Jan 31, 2012 | Issued |
Array
(
[id] => 8370558
[patent_doc_number] => 20120219956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'NGAL FOR DIAGNOSIS OF RENAL CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/359772
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 18588
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13359772
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/359772 | NGAL FOR DIAGNOSIS OF RENAL CONDITIONS | Jan 26, 2012 | Abandoned |
Array
(
[id] => 8335136
[patent_doc_number] => 20120201840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'EphA2 T-Cell Epitopes and Uses Therefor'
[patent_app_type] => utility
[patent_app_number] => 13/355343
[patent_app_country] => US
[patent_app_date] => 2012-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 17457
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13355343
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/355343 | EphA2 T cell epitopes and uses therefor | Jan 19, 2012 | Issued |
Array
(
[id] => 9162263
[patent_doc_number] => 20130310540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'EXTRACT OF AQUATIC ANIMAL CARTILAGE'
[patent_app_type] => utility
[patent_app_number] => 13/980429
[patent_app_country] => US
[patent_app_date] => 2012-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15164
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980429
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/980429 | EXTRACT OF AQUATIC ANIMAL CARTILAGE | Jan 18, 2012 | Abandoned |
Array
(
[id] => 8289298
[patent_doc_number] => 20120177625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'CHEMICALLY MODIFIED FACTOR IX'
[patent_app_type] => utility
[patent_app_number] => 13/339823
[patent_app_country] => US
[patent_app_date] => 2011-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8828
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339823
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/339823 | CHEMICALLY MODIFIED FACTOR IX | Dec 28, 2011 | Abandoned |